Healthcare Services

Biomarker Testing Market Outlook 2026–2030 Exploring New Business Opportunities

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Biomarker Testing Market During The Forecast Period 2026–2030?

The biomarker testing market has experienced significant expansion in recent years. It is forecast to increase from $19.75 billion in 2025 to $22.26 billion in 2026, progressing at a compound annual growth rate (CAGR) of 12.7%. This historic growth can be linked to factors such as the rising incidence of chronic diseases, the expansion of clinical research, the increasing adoption of molecular diagnostics, the growing requirement for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market size is projected to experience swift expansion in the coming years. This market is set to reach $35.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. The anticipated growth during this period stems from factors such as increased investments in personalized medicine, a greater application of biomarkers in drug development, the broadening scope of oncology and infectious disease testing, an increasing need for minimally invasive diagnostics, and breakthroughs in multi-omics technologies. Key developments expected during the forecast period involve a greater uptake of precision medicine diagnostics, an increasing reliance on companion diagnostics, the expanding integration of AI into biomarker analysis, the growth of liquid biopsy testing, and an intensified emphasis on detecting diseases early.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

What Drivers Are Expected To Influence The Biomarker Testing Market During The Forecast Period?

The increasing incidence of cancer is anticipated to stimulate expansion within the biomarker testing market. Cancer is defined as a collection of illnesses marked by the unregulated proliferation and dissemination of abnormal cells throughout the body. The escalating prevalence of cancer stems from lifestyle factors such as inadequate nutrition, tobacco use, insufficient physical activity, and excessive alcohol intake. Biomarker testing improves cancer detection through the early and accurate identification of disease-specific indicators, thereby enhancing diagnostic precision. It also facilitates tailored treatment strategies, resulting in superior patient results and more efficient healthcare administration. As an illustration, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported approximately 165,000 new cancer cases diagnosed in 2023, with forecasts suggesting about 204,000 cases will be diagnosed annually by 2033, culminating in an estimated aggregate of 1.9 million cancer cases between 2024 and 2033. Consequently, the growing cancer burden is fueling the expansion of the biomarker testing market.

What Market Segments Are Evaluated Within The Biomarker Testing Market?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

What Major Market Trends Are Driving Changes In The Biomarker Testing Market?

Major companies operating in the biomarker testing market are prioritizing the development of advanced technological solutions, such as immunohistochemistry (IHC) technology, to enhance diagnostic precision, enable early disease detection, and support individualized treatment plans. Immunohistochemistry (IHC) technology is a laboratory procedure that employs antibodies to pinpoint specific proteins in tissue samples, thereby aiding in the identification and visualization of biomarkers for disease diagnosis and research. For instance, in July 2023, Quest Diagnostics Incorporated, a US-based medical laboratories company, launched a novel tissue-based prostate cancer biomarker test through its AmeriPath business, aiming to improve diagnostic accuracy using its proprietary biomarkers EV1, EV2, and EV3. This test fulfills a significant clinical need by helping physicians more accurately identify and differentiate aggressive forms of prostate cancer, leading to improved grading consistency and informing appropriate treatment strategies for patients.

Who Are The Top Market Participants Influencing The Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Read the full biomarker testing market report here:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Region Is Forecast To Lead The Biomarker Testing Market In Terms Of Market Size?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biomarker Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Clinical Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Global Market Report

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Cancer Biomarker Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795